Literature DB >> 34894543

Pain killers: the interplay between nonsteroidal anti-inflammatory drugs and Clostridioides difficile infection.

Joshua Soto Ocaña1, Nile U Bayard2, Joseph P Zackular3.   

Abstract

Clostridioides difficile is one of the leading causes of nosocomial infections worldwide. Increases in incidence, severity, and healthcare cost associated with C. difficile infection (CDI) have made this pathogen an urgent public health threat worldwide. The factors shaping the evolving epidemiology of CDI and impacting clinical outcomes of infection are not well understood, but involve tripartite interactions between the host, microbiota, and C. difficile. In addition to this, emerging data suggests an underappreciated role for environmental factors, such as diet and pharmaceutical drugs, in CDI. In this review, we discuss the role of nonsteroidal anti-inflammatory drugs (NSAIDs) and eicosanoids in CDI.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34894543      PMCID： PMC9058983          DOI： 10.1016/j.mib.2021.11.011

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN： 1369-5274            Impact factor:   7.584


  72 in total

1.  Non-steroidal anti-inflammatory drugs and the risk of Clostridium difficile-associated disease.

Authors:  Daniel Suissa; Joseph A C Delaney; Sandra Dial; Paul Brassard
Journal:  Br J Clin Pharmacol       Date:  2012-08       Impact factor: 4.335

2.  Non-steroidal anti-inflammatory drugs as a possible cause of collagenous colitis: a case-control study.

Authors:  R H Riddell; M Tanaka; G Mazzoleni
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

Review 3.  Clostridium difficile--more difficult than ever.

Authors:  Ciarán P Kelly; J Thomas LaMont
Journal:  N Engl J Med       Date:  2008-10-30       Impact factor: 91.245

Review 4.  The changing epidemiology of Clostridium difficile infection.

Authors:  Hitoshi Honda; Erik R Dubberke
Journal:  Curr Opin Gastroenterol       Date:  2014-01       Impact factor: 3.287

Review 5.  Nonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease.

Authors:  Charlotte L Kvasnovsky; Usman Aujla; Ingvar Bjarnason
Journal:  Scand J Gastroenterol       Date:  2014-10-14       Impact factor: 2.423

6.  Use of nonsteroidal anti-inflammatory drugs in the older adult.

Authors:  Terri O Fowler; Catherine O Durham; Jonathan Planton; Barbara J Edlund
Journal:  J Am Assoc Nurse Pract       Date:  2014-06-23       Impact factor: 1.165

7.  Experimental studies on synergism between aminoglycosides and the antimicrobial antiinflammatory agent diclofenac sodium.

Authors:  S Annadurai; A Guha-Thakurta; B Sa; S G Dastidar; R Ray; A N Chakrabarty
Journal:  J Chemother       Date:  2002-02       Impact factor: 1.714

8.  Enhanced gastric mucosal leukotriene B4 synthesis in patients taking non-steroidal anti-inflammatory drugs.

Authors:  N Hudson; M Balsitis; S Everitt; C J Hawkey
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

9.  Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease.

Authors:  P Sharon; W F Stenson
Journal:  Gastroenterology       Date:  1984-03       Impact factor: 22.682

10.  PGE2 production at sites of tissue injury promotes an anti-inflammatory neutrophil phenotype and determines the outcome of inflammation resolution in vivo.

Authors:  Catherine A Loynes; Jou A Lee; Anne L Robertson; Michael Jg Steel; Felix Ellett; Yi Feng; Bruce D Levy; Moira K B Whyte; Stephen A Renshaw
Journal:  Sci Adv       Date:  2018-09-05       Impact factor: 14.136
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.